ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

ADVFN

Trade Now

EasyMarkets
Market Data
News
Tools
Markets
Discover
Subscribe Login/Register Profile Icon
S&P 500
4,604.37
(
0.41%
)
US Tech 100
15,700.80
(
0.54%
)
Dow Jones
36,247.87
(
0.36%
)
Brent Oil
75.965
(
0.0%
)
Bitcoin
43,663.27
(
-0.13%
)
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. RAPT Therapeutics Inc (RAPT)

  7. RAPT Therapeutics Inc (RAPT) News

RAPT RAPT Therapeutics Inc

17.48
-0.02 (-0.11%)
Dec 08 2023 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
RAPT Therapeutics Inc RAPT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
Upgrade Icon
-0.02 -0.11% 17.48 20:00:00
Open Price Low Price High Price Close Price Prev Close
17.34 16.99 18.105 17.48 17.50
more quote information »

Recent News

Date Time Source Heading
11/27/202308:00GLOBERAPT Therapeutics Announces Publication of Phase 1a/1b..
11/13/202308:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/202308:03EDGAR2Form 8-K - Current report
11/13/202308:00GLOBERAPT Therapeutics Reports Third Quarter 2023 Financial..
11/03/202312:03EDGAR2Form 8-K - Current report
11/03/202312:00GLOBERAPT Therapeutics Announces Positive Data, Including..
11/01/202316:05GLOBERAPT Therapeutics to Participate in Several Upcoming..
10/23/202316:40EDGAR2Form SC 13G - Statement of acquisition of beneficial..
10/18/202309:00GLOBERAPT Therapeutics Announces Two FLX475 Presentations at the..
8/30/202316:05GLOBERAPT Therapeutics to Participate in Several Upcoming..
8/18/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
8/11/202316:02EDGAR2Form 8-K - Current report
8/11/202308:57EDGAR2Form S-3 - Registration statement under Securities Act of..
8/11/202308:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/11/202308:05EDGAR2Form 8-K - Current report
8/11/202308:00GLOBERAPT Therapeutics Reports Second Quarter 2023 Financial..
6/07/202308:00GLOBERAPT Therapeutics to Participate in the Goldman Sachs Global..
5/25/202317:00GLOBERAPT Therapeutics to Present Biomarker Data Corroborating..
5/11/202308:00GLOBERAPT Therapeutics Reports First Quarter 2023 Financial..
5/03/202308:00GLOBERAPT Therapeutics Announces the Appointment of Michael..
4/26/202316:19GLOBERAPT Therapeutics Announces FLX475 Poster Presentation at..
3/29/202308:00GLOBERAPT Therapeutics Announces Initiation of Phase 2a Trial of..
3/14/202308:00GLOBERAPT Therapeutics Reports Fourth Quarter And Year End..
2/07/202308:00GLOBERAPT Therapeutics to Participate in the SVB Securities..
1/03/202308:00GLOBERAPT Therapeutics to Present at the 41st Annual J.P. Morgan..
12/12/202206:35TRMNSVB Securities Keeps Their Buy Rating on RAPT Therapeutics..

Your Recent History

NASDAQ
RAPT
RAPT Therapeutics
Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com